(USANYS)" ci

From: To: (USANYS)" ci Cc: Subject: FW: Reuters story on challenges of jury selection in Maxwell case Date: Tue, 02 Nov 2021 21:24:04 +0000 FYA. From: (USANYS) Sent: Tuesday, November 2, 2021 5:21 PM To: 'Cohen, Luc (Reuters)' • Subject: RE: Reuters story on challenges of jury selection in Maxwell case Much appreciated, Luc. We will not have any comment. United States Department of Justice U.S. Attorney's Office I Southern District of New York From: Cohen, Luc (Reuters) Sent: Tuesday, November 2, 2021 5:19 PM To: (USANYS) < • Subject: (EXTERNAL) Reuters story on challenges of jury selection in Maxwell case Hi I hope all is well. I wanted to let you know that we'll be preparing a story for Thursday about the challenges for jury selection in the USA v. Maxwell case, and I wanted to make sure you had the chance to comment. The story will cite a half-dozen jury selection consultants and defense attorneys who state that Maxwell's association with Jeffrey Epstein will make it particularly difficult to find unbiased prospective jurors, given the amount of publicity Epstein's actions have received. Some of the experts interviewed said many prospective jurors will likely hold her to a higher standard because she is a woman. We will mention the defense's argument that the "unprecedented" pre-trial coverage has tainted the jury pool, while of course noting that significant pre-trial publicity in a high-profile sex crimes trial is by no means a guarantee of a guilty verdict. I wanted to see if the U.S. Attorney's office had any comment for this story. Please feel free to give me a call at M o discuss. EFTA00098166 Best, Luc Cohen New York Courts Reporter Reuters Mobile/WhatsApp/Signal) This e-mail is for the sole use of the intended recipient and contains information that may be privileged and/or confidential. If you are not an intended recipient, please notify the sender by return e-mail and delete this e-mail and any attachments. Certain required legal entity disclosures can be accessed on our website: https://www.thomsonreuters.com/en/resources/disclosures.html EFTA00098167